SEC 13F Intelligence

Peapack Gladstone Financial Corp / ABBV

Peapack Gladstone Financial Corp’s Abbvie Inc Position

Does Peapack Gladstone Financial Corp own Abbvie Inc (ABBV)? Yes212.0K shares worth $46M (+0.59% of its 13F portfolio) as of Q1 2026, down from 215.6K shares the prior filed quarter.

Position Value
$46M
Q1 2026
Shares
212.0K
% of Portfolio
+0.59%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $14MQ4 ’18Q1 ’19: $13MQ2 ’19: $11MQ3 ’19: $11MQ4 ’19: $13MQ4 ’19Q1 ’20: $11MQ2 ’20: $14MQ3 ’20: $13MQ4 ’20: $17MQ4 ’20Q1 ’21: $19MQ2 ’21: $20MQ3 ’21: $21MQ4 ’21: $27MQ4 ’21Q1 ’22: $35MQ2 ’22: $33MQ3 ’22: $26MQ4 ’22: $32MQ4 ’22Q1 ’23: $31MQ2 ’23: $27MQ3 ’23: $29MQ4 ’23: $31MQ4 ’23Q1 ’24: $36MQ2 ’24: $34MQ3 ’24: $41MQ4 ’24: $37MQ4 ’24Q1 ’25: $42MQ2 ’25: $41MQ3 ’25: $50MQ4 ’25: $49MQ4 ’25Q1 ’26: $46Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026212.0K$46M+0.59%
Q4 2025215.6K$49M+0.62%
Q3 2025218.0K$50M+0.66%
Q2 2025222.9K$41M+0.59%
Q1 2025202.7K$42M+0.63%
Q4 2024206.4K$37M+0.53%
Q3 2024209.5K$41M+0.60%
Q2 2024198.8K$34M+0.52%
Q1 2024198.4K$36M+0.57%
Q4 2023199.1K$31M+0.52%
Q3 2023197.8K$29M+0.55%
Q2 2023199.6K$27M+0.48%
Q1 2023195.8K$31M+0.59%
Q4 2022197.1K$32M+0.63%
Q3 2022192.5K$26M+0.53%
Q2 2022216.9K$33M+0.76%
Q1 2022217.1K$35M+0.69%
Q4 2021199.0K$27M+0.51%
Q3 2021198.2K$21M+0.44%
Q2 2021181.5K$20M+0.49%
Q1 2021178.2K$19M+0.50%
Q4 2020162.6K$17M+0.52%
Q3 2020148.8K$13M+0.47%
Q2 2020146.2K$14M+0.57%
Q1 2020146.3K$11M+0.53%
Q4 2019149.5K$13M+0.53%
Q3 2019151.5K$11M+0.49%
Q2 2019156.4K$11M+0.49%
Q1 2019157.9K$13M+0.58%
Q4 2018156.1K$14M+0.74%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Peapack Gladstone Financial Corp’s full portfolio or all institutional holders of ABBV.